DAX+0,68 % EUR/USD+0,01 % Gold+0,25 % Öl (Brent)-1,17 %

Solazyme - Biofuel IPO


WKN: A2AJUS
0,036
15.08.17
Lang & Schwarz
+7,58 %
+0,003 EUR

Neuigkeiten zur TerraVia Holdings Aktie


Beitrag schreiben

Begriffe und/oder Benutzer

 

im Mai an die Börse gegangen...:


May 27, 2011
SOLAZYME ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING

SOUTH SAN FRANCISCO, Calif. -- Solazyme, Inc., a renewable oil and bioproducts company, today announced the pricing of its initial public offering of 10,975,000 shares of common stock at a price to the public of $18.00 per share. Of the shares of common stock in the offering, Solazyme is offering 10,375,000 shares, and selling stockholders are offering 600,000 shares. In addition, Solazyme has granted the underwriters a 30-day option to purchase up to an additional 1,646,250 shares of common stock, solely to cover over-allotments, if any. Solazyme will not receive any proceeds from the sale of shares by the selling stockholders.

Morgan Stanley & Co. Incorporated and Goldman, Sachs & Co. are acting as joint book-running managers for the offering. Jefferies & Company, Inc. is acting as lead manager, and Pacific Crest Securities LLC and Lazard Capital Markets LLC are acting as co-managers. The shares will begin trading on the NASDAQ Global Select Market on May 27, 2011 under the ticker symbol “SZYM.”

A registration statement relating to this offering was declared effective by the Securities and Exchange Commission on May 26, 2011. Any offer or sale will be made solely by means of a written prospectus forming part of the effective registration statement. Copies of the final prospectus relating to the offering may be obtained from: Morgan Stanley & Co. Incorporated,

Attn: Prospectus Department, 180 Varick Street, New York, NY 10014; or Goldman, Sachs & Co., Prospectus Department, 200 West Street, New York, NY 10282, telephone: 1-866-471-2526, facsimile: 212-902-9316 or by emailing prospectus-ny@ny.email.gs.com.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
June 30, 2011
SOLAZYME EXPANDS ALGENIST DISTRIBUTION CHANNELS TO INCLUDE SEPHORA CANADA AND THE SHOPPING CHANNEL

Canada's lead beauty retailers launch breakthrough, miracle ingredient, alguronic acid, throughout the country

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Solazyme, Inc. (NASDAQ: SZYM), a renewable oil and bioproducts company, has signed agreements with Sephora Canada and the leading Canadian multimedia retailer, The Shopping Channel®, to launch Algenist™, Solazyme's microalgae-based prestige anti-aging skincare line throughout the country. In an unprecedented beauty launch that couples world-class biotechnology with Canada's most prominent beauty retailers, the Algenist product line will begin selling in all 26 Canadian Sephora stores and on The Shopping Channel's highest rated beauty programming starting in July 2011.

Algenist is a product line of advanced anti-aging skincare products formulated with Solazyme's breakthrough ingredient, alguronic acid, an unexpected discovery which was found by the company's leading biotechnology scientists while researching microalgae for renewable energy solutions. When studied for potential anti-aging benefits, alguronic acid demonstrated significant results and outperformed some of the most well known anti-aging ingredients on the market including hyaluronic acid, retinol and vitamins C and E.

"Algenist comes from a lineage of biotechnology expertise that is not only pioneering the future of skincare, but reinvigorated the luxury skin and personal care space," said Frederic Stoeckel, Senior Vice President & General Manager, Solazyme Health Sciences. "Sephora and The Shopping Channel provide incredible support and access to some of the largest markets in the world and we look forward to a successful launch with their respective audiences in Canada."

"At Sephora, we are relentless in our search for exclusive and unique product offerings to redefine the Canadian beauty landscape. Algenist's pioneering work in producing microalgae ingredients from its biotechnology platform is a brand that is poised to do this," says Lori Castagna, VP/DMM Merchandising and Marketing, Sephora Canada. "Algenist is an extremely innovative addition to our skincare assortment and we look forward to introducing it to our discerning clients."

"The Shopping Channel is very excited to be launching the Algenist skin care line in Canada. Our buyers know that Canadian women are some of the most savy and discerning customers in the world, looking for great products, latest technologies and ultimately - results," said Lella Liuzzi, Vice-President, Merchandising, The Shopping Channel. "We are confident that both our existing customers and those who have yet to discover The Shopping Channel will embrace the Algenist brand. It's an excellent compliment to our already strong beauty brand assortment."

In March of 2011, Solazyme successfully launched the initial Algenist product portfolio in more than 850 retail Sephora stores worldwide and on QVC's lead beauty programming. Algenist ranked immediately after the launch as a top selling brand in both Sephora USA and on QVC.

The line of innovative alguronic acid based products will launch in Canada with three initial product offerings including the Algenist Concentrated Serum, the Algenist Anti-Aging Moisturizer, and the Algenist Complete Eye Renewal Balm. The Algenist Concentrated Serum minimizes the look of wrinkles and boosts skin radiance. The Algenist Anti-Aging Moisturizer nourishes and moisturizes skin, improves firmness, and minimizes the appearance of fine lines and wrinkles, while the Algenist Complete Eye Renewal Balm firms skin while minimizing the appearance of fine lines around the eye area.

About Solazyme, Inc.

Solazyme, Inc. (NASDAQ: SZYM) is a renewable oil and bioproducts company that transforms a range of low-cost plant-based sugars into high-value oils. Headquartered in South San Francisco, Solazyme's renewable products can replace or enhance oils derived from the world's three existing sources — petroleum, plants and animal fats. Initially, Solazyme is focused on commercializing its products into three target markets: (1) fuels and chemicals, (2) nutrition and (3) skin and personal care.
Antwort auf Beitrag Nr.: 41.852.515 von R-BgO am 27.07.11 15:04:50

Ist soweit ich gehört hab ein recht heiss gehandeltes +lang erwartetes IPO.

Fange mich jedenfalls selber, als einer der Sektoren of interest, immer mehr an für "advanced Biofuels(ab >/= 3.0 :laugh: ;) )" zu interessieren, wobei ich da noch ziemlich am Anfang steh´.

Gruß
P.
Antwort auf Beitrag Nr.: 41.853.588 von Popeye82 am 27.07.11 17:18:22Welche Werte beobachtest Du?

Ich gucke im Bereich Biogas nach:
Envitec, Biogas Nord, MAX Automation, BKN Biostrom, BKN Bioenergy


und bei Biofuels nach:
Verbio, 2G-Bio Energy, Solazyme, und indirekt Novozyme und DuPont (Danisco)
Antwort auf Beitrag Nr.: 41.853.747 von R-BgO am 27.07.11 17:38:57
Sind eher ein paar kleine, exotisch &hochspekulative Buden die ich unter Beoacbhtung habe(OOIL:OB ist eines davon) -was eben jenem >/=3.0 geschuldet ist. ;)

Gruß
P.
Antwort auf Beitrag Nr.: 41.853.872 von Popeye82 am 27.07.11 17:56:12

Hier sprechen die von "Second generation/advanced biofuels", wobei wir m.A.n. schon von einer 3. sprechen müssten -die ich fast ausschliesslich interessant finde/Chancen zuspreche -da sie IMO die 1ste ist, die die Problemfelder(v.a. was die Zweckentfremdung von Nahrungsmitteln angeht!) nahezu komplett ausschliesst/versucht zu umschiffen -was dann allerdings, natürlich, in technisch viel aufwendigeren Anforderungen resultiert. Mit entsprechenden Folgen sicher für den Entwicklungshorizont:
http://en.wikipedia.org/wiki/Biofuel#Second_generation_biofu…

in der dt. Version wird´s erwähnt:
http://de.wikipedia.org/wiki/Biokraftstoff

Gruß
P.
May 2, 2012
SOLAZYME AND DOW ENTER INTO CONTINGENT GLOBAL COMMERCIAL OFFTAKE AGREEMENT AND CONCURRENTLY SIGN PHASE 2 JOINT DEVELOPMENT AGREEMENT TO ACCELERATE COMMERCIALIZATION OF BIO-BASED DIELECTRIC INSULATING FLUIDS

New algal oil to provide higher flash point and increased functionality to dielectric insulating fluids for transformers and other electrical applications

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Solazyme, Inc. (NASDAQ: SZYM), a renewable oil and bioproducts company, and The Dow Chemical Company (NYSE: DOW), announced today that they have entered into a contingent offtake agreement in which Dow has agreed to purchase from Solazyme all of its requirements of non-vegetable microbe-based oils for use in dielectric fluid applications through 2015, contingent upon Solazyme's ability to supply such oils within agreed specifications and certain terms and conditions of the sale. These new, renewable and biodegradable bio-based dielectric insulating fluids offer increased fire safety thanks to higher flash points and provide additional functionality that may improve the operating efficiency and extend the useful life of transformers.

Concurrently, Solazyme and Dow have entered into a Phase 2 Joint Development Agreement (JDA2), an exclusive, multi-year extension of the current joint-development agreement including accelerated commercialization timelines based on Solazyme's rapid progress in the production of tailored algal oils. JDA2 enables additional application development work to be conducted by Dow, due to Solazyme's accelerated ability to scale up their uniquely tailored algal oil feedstocks. Consumption of Solazyme's algal oil feedstocks is expected to significantly exceed the minimum estimated volumes of 8.5 million gallons (29,000 metric tons) starting in the second half of 2013 and through 2015. The offtake agreement contemplates that final pricing for the oil will be linked to certain items including Solazyme's sugar-based feedstock costs.

"Solazyme's unique biotechnology-based oils platform has created a new market opportunity to develop and produce the next-generation of safe, renewable, dielectric insulating fluids that provide increased performance benefits," said Jonathan Wolfson, CEO, Solazyme. "We have continued to reach technological advancements ahead of schedule with Dow, enabling us to further progress our commercial relationship."

"Solazyme is a leading company in the industrial biotechnology space and its renewable oil technology platform provides a unique opportunity to significantly accelerate the development of next-generation, bio-based, non-vegetable dielectric insulating fluids," said Tim Laughlin, General Manager, Dow Electrical & Telecommunications. "In the fast-growing space of bio-based dielectric insulating fluids, Solazyme's tailored algal oils will serve as a technology platform for our continued efforts to bring innovative solutions to the power industry. Advanced field trials in transformers will be initiated to further prove the technology and value proposition of these new products in the near term. Based on the application work we have already completed to date, we are confident we are positioned to commercialize these oils in timelines consistent with Solazyme's planned ability to manufacture the quantities we need."
habe mir mal ein paar Ansichtsstücke zugelegt, um mich zu öfterem Hingucken zu "zwingen"
Hat jemand ne Ahnung womit die Gesellschaft irgendwann mal Gewinne erzielen möchte?

Der Biodieselmarkt im Europa leidet unter Überkapazitäten und in Deutschland wird Biodiesel ab 2013 die teilweise Energiesteuerbefreiung aufgehoben. In wie weit sich andere Länder die Subventionen für Biodiesel leisten ist mir nicht ganz bekannt. In den USA scheint es aber ganz gute Förderungen von 1 Cent pro 1% im normalen Diesel zu geben.

Interessant scheint der Markt für chemische Produktie / Kosmetik und Nahrungsmittel zu sein. Hat sich hier jemand schon mit befasst?
Antwort auf Beitrag Nr.: 43.154.468 von R-BgO am 11.05.12 18:34:53klappt ja super bisher...


weiter blutrote Zahlen, knapp 20 MUSD product sales


Beitrag zu dieser Diskussion schreiben